SEARCH RESULTS
330988 RESULTS
Pari Afshar
FreedomTehran, Iran, Islamic Republic of
Ajanta gogoi
ugc
PAPER Lindström V, Ihse E, Fagerqvist T, Bergström J, Nordström E, Möller C, Lannfelt L, Ingelsson M
Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.
Immunotherapy. 2014 Feb;6(2):141-53. PubMed: 24491088PAPER Cooper-Knock J, Shaw PJ, Kirby J
The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.
Acta Neuropathol. 2014 Mar;127(3):333-45. Epub 2014 Feb 4 PubMed: 24493408PAPER Chen X, Huang R, Chen Y, Zheng Z, Chen K, Song W, Zhao B, Yang Y, Yuan L, Shang H
Association analysis of four candidate genetic variants with sporadic amyotrophic lateral sclerosis in a Chinese population.
Neurol Sci. 2014 Jul;35(7):1089-95. Epub 2014 Feb 4 PubMed: 24493373PAPER Grossman M, Elman L, McCluskey L, McMillan CT, Boller A, Powers J, Rascovsky K, Hu W, Shaw L, Irwin DJ, Lee VM, Trojanowski JQ
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
JAMA Neurol. 2014 Apr;71(4):442-8. PubMed: 24492862PAPER Romano M, Buratti E, Romano G, Klima R, Del Bel Belluz L, Stuani C, Baralle F, Feiguin F
Evolutionarily conserved heterogeneous nuclear ribonucleoprotein (hnRNP) A/B proteins functionally interact with human and Drosophila TAR DNA-binding protein 43 (TDP-43).
J Biol Chem. 2014 Mar 7;289(10):7121-30. Epub 2014 Feb 3 PubMed: 24492607PAPER Rosini M, Simoni E, Minarini A, Melchiorre C
Multi-target Design Strategies in the Context of Alzheimer's Disease: Acetylcholinesterase Inhibition and NMDA Receptor Antagonism as the Driving Forces.
Neurochem Res. 2014 Feb 4; PubMed: 24493627PAPER Bloom GS
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
JAMA Neurol. 2014 Apr;71(4):505-8. PubMed: 24493463PAPER Jefferson AL, Gifford KA, Damon S, Chapman GW 4th, Liu D, Sparling J, Dobromyslin V, Salat D, for the Alzheimer’s Disease Neuroimaging Initiative
Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters.
Brain Imaging Behav. 2014 Feb 4; PubMed: 24493370PAPER Young TR, Kirchner A, Wedd AG, Xiao Z
An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Metallomics. 2014 Mar;6(3):505-17. Epub 2014 Feb 3 PubMed: 24493126PAPER Pietropaolo S, Feldon J, Yee BK
Environmental enrichment eliminates the anxiety phenotypes in a triple transgenic mouse model of Alzheimer's disease.
Cogn Affect Behav Neurosci. 2014 Feb 4; PubMed: 24492993PAPER Chang YS, Chen HL, Hsu CY, Tang SH, Liu CK
Parallel improvement of cognitive functions and P300 latency following donepezil treatment in patients with Alzheimer's disease: a case-control study.
J Clin Neurophysiol. 2014 Feb;31(1):81-5. PubMed: 24492450PAPER Conejero-Goldberg C, Gomar JJ, Bobes-Bascaran T, Hyde TM, Kleinman JE, Herman MM, Chen S, Davies P, Goldberg TE
APOE2 enhances neuroprotection against Alzheimer's disease through multiple molecular mechanisms.
Mol Psychiatry. 2014 Feb 4; PubMed: 24492349Current Filters
No filters selected